Pharmacokinetics of weekly low dose doxorubicin.

  title={Pharmacokinetics of weekly low dose doxorubicin.},
  author={Marc Paul Frenay and G{\'e}rard Milano and Nicole Ren{\'e}e and Douwe Pons and Roger Khater and {\'E}ric François and Antoine Thyss and Moise Namer},
  journal={European journal of cancer & clinical oncology},
  volume={25 2},
Weekly low dose doxorubicin (WLD-dox) is an interesting alternative to the classical 3 week schedule because of its reduced cardiotoxicity, the major dose-related side-effect. This study characterized the pharmacokinetic behaviour of WLD-dox with particular attention to the effect of treatment duration on the variability of individual pharmacokinetic… CONTINUE READING